FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947786215> ?p ?o ?g. }

• W2947786215 endingPage "566" @default.
• W2947786215 startingPage "556" @default.
• W2947786215 abstract "Background: Clinical significance of germinal center B-cell (GCB) and non-GCB sub-categorization, expression of MYC, BCL2, BCL6, CD5 proteins and Epstein Barr virus encoded RNA (EBER) positivity in diffuse large B-cell lymphoma (DLBCL) remain controversial. Could these biomarkers accurately identify high risk DLBCL patients? Are MYC, BCL2 and BCL6 proteins expression feasible as baseline testing to predict c-Myc, BCL2 or BCL6 gene rearrangements? Aims: To investigate prognostic values of GCB/non-GCB sub-categorization, Double Protein Expression Lymphoma (DPL), Triple Protein Expression Lymphoma (TPL), positivity of CD5 protein and EBER in patients with DLBCL disease. To evaluate correlation between BCL2 , c-Myc and BCL6 gene rearrangements with BCL2, MYC and BCL6 proteins expression. Methods: Diagnostic tissue samples of 120 DLBCL patients between January 2012 to December 2013 from four major hospitals in Malaysia were selected. Samples were subjected to immunohistochemical staining, fluorescent in-situ hybridization (FISH) testing, and central pathological review. Pathological data were correlated with clinical characteristics and treatment outcome. Results: A total of 120 cases were analysed. Mean age of diagnosis was 54.1 years ± 14.6, 64 were males, 56 were females, mean follow up period was 25 months (ranged from 1 to 36 months). Of the 120 cases, 74.2% were non-GCB whereas 25.8% were GCB, 6.7% were EBER positive, 6.7% expressed CD5 protein, 13.3% were DPL and 40% were TPL. The prevalence of c-Myc, BCL2, BCL6 gene rearrangements were 5.8%, 5.8%, and 14.2%, respectively; and 1.6% were Double Hit Lymphoma (DHL). EBER positivity, DPL, TPL, c-Myc gene rearrangement, BCL2 gene rearrangement, extra copies of BCL2 gene and BCL6 gene rearrangement were associated with shorter median overall survival (P<0.05). IPI score was the significant determinants of median overall survival in DPL and TPL (P<0.05). CD5 protein expression and GCB/non-GCB sub-categorization did not affect treatment outcome (P>0.05). Overall, c-Myc, BCL2 and BCL6 gene rearrangements showed weak correlation with expression of MYC, BCL2 and BCL6 proteins (P>0.05). Fluorescent in situ hybridization is the preferred technique for prediction of treatment outcome in DLBCL patients. Conclusion:c-Myc, BCL2, and BCL6 gene rearrangements, EBER expression, DHL, TPL and IPI score are reliable risk stratification tools. MYC, BCL2 and BCL6 proteins expression are not applicable as baseline biomarkers to predict c-Myc, BCL2, and BCL6 gene rearrangements." @default.
• W2947786215 created "2019-06-07" @default.
• W2947786215 creator A5003473255 @default.
• W2947786215 creator A5013239284 @default.
• W2947786215 creator A5013311936 @default.
• W2947786215 creator A5021891130 @default.
• W2947786215 creator A5022037773 @default.
• W2947786215 creator A5022933147 @default.
• W2947786215 creator A5031989601 @default.
• W2947786215 creator A5032715971 @default.
• W2947786215 creator A5044397038 @default.
• W2947786215 creator A5047906684 @default.
• W2947786215 creator A5049893420 @default.
• W2947786215 creator A5054802521 @default.
• W2947786215 creator A5074626810 @default.
• W2947786215 creator A5075557942 @default.
• W2947786215 creator A5082003670 @default.
• W2947786215 creator A5083155150 @default.
• W2947786215 creator A5085352879 @default.
• W2947786215 date "2019-01-01" @default.
• W2947786215 modified "2023-10-15" @default.
• W2947786215 title "Clinical Significance of <i>BCL2</i>, C-<i>MYC</i>, and <i>BCL6</i> Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients" @default.
• W2947786215 cites W1020989877 @default.
• W2947786215 cites W1038865554 @default.
• W2947786215 cites W1042066977 @default.
• W2947786215 cites W1536179996 @default.
• W2947786215 cites W1929899779 @default.
• W2947786215 cites W1977592657 @default.
• W2947786215 cites W1984381148 @default.
• W2947786215 cites W1988703453 @default.
• W2947786215 cites W1996279342 @default.
• W2947786215 cites W1997647834 @default.
• W2947786215 cites W2015214739 @default.
• W2947786215 cites W2016969330 @default.
• W2947786215 cites W2019818154 @default.
• W2947786215 cites W2027633034 @default.
• W2947786215 cites W2037480715 @default.
• W2947786215 cites W2057456224 @default.
• W2947786215 cites W2077522084 @default.
• W2947786215 cites W2084935205 @default.
• W2947786215 cites W2087285240 @default.
• W2947786215 cites W2090636482 @default.
• W2947786215 cites W2100197564 @default.
• W2947786215 cites W2111755272 @default.
• W2947786215 cites W2116956926 @default.
• W2947786215 cites W2119147717 @default.
• W2947786215 cites W2131934389 @default.
• W2947786215 cites W2133869962 @default.
• W2947786215 cites W2135254067 @default.
• W2947786215 cites W2140485109 @default.
• W2947786215 cites W2153667947 @default.
• W2947786215 cites W2156661621 @default.
• W2947786215 cites W2158267770 @default.
• W2947786215 cites W2159081821 @default.
• W2947786215 cites W2159862107 @default.
• W2947786215 cites W2261115438 @default.
• W2947786215 cites W2262207451 @default.
• W2947786215 cites W2310716991 @default.
• W2947786215 cites W2324761284 @default.
• W2947786215 cites W2567630865 @default.
• W2947786215 cites W2598700764 @default.
• W2947786215 cites W2600372273 @default.
• W2947786215 cites W2624467319 @default.
• W2947786215 cites W2739872419 @default.
• W2947786215 cites W4205736005 @default.
• W2947786215 cites W74859367 @default.
• W2947786215 doi "https://doi.org/10.7150/ijms.27610" @default.
• W2947786215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6535654" @default.
• W2947786215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31171907" @default.
• W2947786215 hasPublicationYear "2019" @default.
• W2947786215 type Work @default.
• W2947786215 sameAs 2947786215 @default.
• W2947786215 citedByCount "11" @default.
• W2947786215 countsByYear W29477862152020 @default.
• W2947786215 countsByYear W29477862152021 @default.
• W2947786215 countsByYear W29477862152022 @default.
• W2947786215 countsByYear W29477862152023 @default.
• W2947786215 crossrefType "journal-article" @default.
• W2947786215 hasAuthorship W2947786215A5003473255 @default.
• W2947786215 hasAuthorship W2947786215A5013239284 @default.
• W2947786215 hasAuthorship W2947786215A5013311936 @default.
• W2947786215 hasAuthorship W2947786215A5021891130 @default.
• W2947786215 hasAuthorship W2947786215A5022037773 @default.
• W2947786215 hasAuthorship W2947786215A5022933147 @default.
• W2947786215 hasAuthorship W2947786215A5031989601 @default.
• W2947786215 hasAuthorship W2947786215A5032715971 @default.
• W2947786215 hasAuthorship W2947786215A5044397038 @default.
• W2947786215 hasAuthorship W2947786215A5047906684 @default.
• W2947786215 hasAuthorship W2947786215A5049893420 @default.
• W2947786215 hasAuthorship W2947786215A5054802521 @default.
• W2947786215 hasAuthorship W2947786215A5074626810 @default.
• W2947786215 hasAuthorship W2947786215A5075557942 @default.
• W2947786215 hasAuthorship W2947786215A5082003670 @default.
• W2947786215 hasAuthorship W2947786215A5083155150 @default.
• W2947786215 hasAuthorship W2947786215A5085352879 @default.
• W2947786215 hasBestOaLocation W29477862151 @default.
• W2947786215 hasConcept C113067387 @default.
• W2947786215 hasConcept C142724271 @default.

• next